Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT-Reference-Cited by-同舟云学术

Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT

Published:2023-11-03 Issue:45 Volume:8 Page:43218-43226
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Kandeil Mohamed A.¹,Shaarawy Mohamed A.²,Mourad Hamdy A.³,Mahmoud Mohamed O.³^ORCID

Affiliation:

1. Biochemistry Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt

2. Internal Medicine and Nephrology Department, Faculty of Medicine, El-Minia University, El-Minia 61519, Egypt

3. Biochemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c07008

Reference59 articles.

1. Epidemiology of and Risk Factors for Type 2 Diabetes in Egypt

2. National Diabetes Statistics Report, 2020. Estimates of diabetes and its burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. (accessed July 5, 2022).

3. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group

4. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

5. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial;Diabetologia;2024-09-14